Vanguard Group’s SAB Biotherapeutics SABS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $494K | Buy |
282,371
+4,861
| +2% | +$8.51K | ﹤0.01% | 3920 |
|
|
2025
Q1 | $375K | Buy |
277,510
+135
| +0% | +$182 | ﹤0.01% | 3945 |
|
|
2024
Q4 | $1.06M | Buy |
277,375
+1,039
| +0.4% | +$3.97K | ﹤0.01% | 3747 |
|
|
2024
Q3 | $746K | Hold |
276,336
| – | – | ﹤0.01% | 3859 |
|
|
2024
Q2 | $857K | Buy |
276,336
+100,002
| +57% | +$310K | ﹤0.01% | 3851 |
|
|
2024
Q1 | $801K | Sell |
176,334
-819,798
| -82% | -$3.72M | ﹤0.01% | 3883 |
|
|
2023
Q4 | $685K | Buy |
996,132
+19,194
| +2% | +$13.2K | ﹤0.01% | 3941 |
|
|
2023
Q3 | $615K | Buy |
976,938
+14,200
| +1% | +$8.95K | ﹤0.01% | 3995 |
|
|
2023
Q2 | $799K | Buy |
962,738
+261,154
| +37% | +$217K | ﹤0.01% | 3968 |
|
|
2023
Q1 | $309K | Hold |
701,584
| – | – | ﹤0.01% | 4241 |
|
|
2022
Q4 | $414K | Buy |
701,584
+581
| +0.1% | +$343 | ﹤0.01% | 4153 |
|
|
2022
Q3 | $491K | Sell |
701,003
-20,648
| -3% | -$14.5K | ﹤0.01% | 4211 |
|
|
2022
Q2 | $1.05M | Buy |
721,651
+500
| +0.1% | +$725 | ﹤0.01% | 4072 |
|
|
2022
Q1 | $2.71M | Buy |
721,151
+38,179
| +6% | +$144K | ﹤0.01% | 3823 |
|
|
2021
Q4 | $5.33M | Buy |
+682,972
| New | +$5.33M | ﹤0.01% | 3568 |
|